Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Select Medical Hldgs Raises FY2025 GAAP EPS Guidance from $1.09-$1.19 to $1.14-$1.24 vs $1.17 Est; Affirms FY2025 Sales Guidance of $5.300B-$5.500B vs $5.395B Est

Author: Benzinga Newsdesk | October 30, 2025 03:32pm
Select Medical Hldgs (NYSE:SEM) raises FY2025 GAAP EPS guidance from $1.09-$1.19 to $1.14-$1.24 vs $1.17 analyst estimate. Affirms FY2025 sales outlook from $5.300 billion-$5.500 billion to $5.300 billion-$5.500 billion vs $5.395 billion estimate.

Posted In: SEM


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist